0
0
Home » Medical Devices » Neurology Devices

Neurovascular Embolization Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

Neurovascular Embolization Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Neurology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Neurovascular Embolization Devices market for the year 2020 and beyond. Neurovascular Embolization Devices are used to treat abnormalities in blood vessels in the brain, namely, brain aneurysms and arteriovenous malformations (AVM). These devices occlude or prevent blood flow to unwanted vessel malformations. This segment comprises of Aneurysm Clips, Liquid Embolic Systems, Flow Diversion Stents, Embolization Coils and Intrasaccular Flow Disruptors. Embolization coils are the most preferred method of treatment for brain aneurysms, followed by aneurysm clips and flow diversion stents.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

Currently marketed Neurovascular Embolization Devices and evolving competitive landscape –

  • Insightful review of the key industry trends.
  • Annualized total Neurovascular Embolization Devices market revenue by segment and market outlooks from 2015-2030.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights –

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Neurovascular Embolization Devices market.
  • Competitive dynamics insights and trends provided for Neurovascular Embolization Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered – Medtronic plc, Stryker Corp, Integra Lifesciences Corp, MicroVention Inc, Cerenovus, Penumbra Inc, Balt Extrusion SAS, MIZUHO Co Ltd, B. Braun Melsungen AG, Embo-Flussigkeiten AG, phenox GmbH, Acandis GmbH & Co KG, Others

Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope of the Neurovascular Embolization Devices market model

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Currently marketed Neurovascular Embolization Devices and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total neurovascular embolization devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices, and market values by segment.
  • Global, Regional, and Country level market-specific insights include qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for neurovascular embolization devices market.
  • Competitive dynamics insights and trends provided for neurovascular embolization devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific MedTech regulatory landscape.

What is the Neurovascular Embolization Devices market size during the historical and forecast period?

Neurovascular Embolization Devices market, by segment

Neurovascular Embolization Devices market, by segment

For more segment insights, download a free report sample

What are the key trends within the Neurovascular Embolization Devices market?

North America follows global trends for device usage, treatment patterns, and growth rates. Growth rates are stable-low for aneurysm clips, and the highest growth is observed in embolization coils. The use of WEB Aneurysm Embolization Devices in the European region has increased the effectiveness of treatment for wide-neck aneurysms compared to the traditional embolization coils. Compared to North America, pricing across Europe is generally lower due to reimbursement systems.

Factors that will encourage growth include the potential for countries in the Asia-Pacific to train large numbers of specialists quickly, as well as retain them. There is a continuous growth for endovascular procedures in South & Central America due to an established public health care system. The Middle East & Africa will follow global trends in growing endovascular procedures due to better patient outcomes.

Neurovascular Embolization Devices market report scope

Market value (Year – 2021)

$32.06 million
Segmentation Aneurysm Clips, Liquid Embolic Systems, Flow Diversion Stents, Embolization Coils, Intrasaccular Flow Disruptors
Key companies Medtronic plc, Stryker Corp, Integra Lifesciences Corp, MicroVention Inc, Cerenovus, Penumbra Inc, Balt Extrusion SAS, MIZUHO Co Ltd, B. Braun Melsungen AG, Embo-Flussigkeiten AG, phenox GmbH, Acandis GmbH & Co KG, Others
Regions covered North America, South & Central America, Europe, Middle East & Africa, Asia-Pacific
Countries covered US, Canada, Mexico, France, Germany, Italy, Spain, United Kingdom, Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Netherlands, Norway, Poland, Portugal, Russia, Sweden, Switzerland, Turkey, Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Brazil, Chile, Egypt, Israel, Saudi Arabia, South Africa, United Arab Emirates

Who are the Neurovascular Embolization Devices market vendors?

The model analyses the competitive landscape of the neurovascular embolization devices market and includes information on the following key market vendors:

Medtronic plc, Stryker Corp, Integra Lifesciences Corp, MicroVention Inc, Cerenovus, Penumbra Inc, Balt Extrusion SAS, MIZUHO Co Ltd, B. Braun Melsungen AG, Embo-Flussigkeiten AG, phenox GmbH, Acandis GmbH & Co KG, Others

Reasons to Buy

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have a deep understanding of the neurovascular embolization devices marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

The model will enable you to:

  • Understand the impact of COVID-19 on the neurovascular embolization devices market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the neurovascular embolization devices market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the neurovascular embolization devices market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific neurovascular embolization devices market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Key Players

Medtronic Plc

Stryker Corp

MicroVention Inc

Cerenovus

Integra LifeSciences Corp

Penumbra Inc

Balt SAS

MIZUHO Co Ltd

B. Braun Melsungen AG

Embo-Flussigkeiten AG

Phenox GmbH

Acandis GmbH & Co KG

Others

Frequently Asked Questions

The neurovascular embolization devices market in 2021 is worth $32.06 million.

The neurovascular embolization devices market has been segmented by product (Aneurysm Clips, Liquid Embolic Systems, Flow Diversion Stents, Embolization Coils, Intrasaccular Flow Disruptors), and by 5 regions (North America, South & Central America, Europe, Middle East & Africa and Asia-Pacific).

Key players in the neurovascular embolization devices market include Medtronic plc, Stryker Corp, Integra Lifesciences Corp, MicroVention Inc, Cerenovus, Penumbra Inc, Balt Extrusion SAS, MIZUHO Co Ltd, B. Braun Melsungen AG, Embo-Flussigkeiten AG, phenox GmbH, Acandis GmbH & Co KG, Others.

The embolization coils segment has the largest share of the global neurovascular embolization devices market.

Stryker Corp has the largest market share in the neurovascular embolization devices market.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports